Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VACC-HeFT: High dose vs standard dose influenza vaccine in heart failure
NCT02268500Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Sep 2014
- Primary completion
- Jan 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine in influenza, sponsored by University of Wisconsin–Madison. Started Sep 2014; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02268500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02268500.